Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study - Wikidata - wikimedia - TriplyDB

Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study

Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study

http://www.wikidata.org/entity/Q34448739

about

Skeletal muscle as a therapeutic target for delaying type 1 diabetic complications The Role of Epigenetics in Arterial Calcification The interplay of autoimmunity and insulin resistance in type 1 diabetes Insulin sensitivity and complications in type 1 diabetes: New insights Cardiovascular disease in children and adolescents with diabetes: where are we, and where are we going?The ratio of pericardial to subcutaneous adipose tissues is associated with insulin resistance.Less but better: cardioprotective lipid profile of patients with GCK-MODY despite lower HDL cholesterol level.Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.Glargine safety, diabetes and cancer.Metabolomics approach for analyzing the effects of exercise in subjects with type 1 diabetes mellitus.ABC goal achievement predicts microvascular but not macrovascular complications over 6-years in adults with type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes Study.Adipose tissue insulin resistance in adolescents with and without type 2 diabetes.Estimated insulin sensitivity predicts regression of albuminuria in Type 1 diabetes.Delayed skeletal muscle mitochondrial ADP recovery in youth with type 1 diabetes relates to muscle insulin resistance.De novo lipogenesis and cholesterol synthesis in humans with long-standing type 1 diabetes are comparable to non-diabetic individuals.Insulin receptor substrate 2 expression and involvement in neuronal insulin resistance in diabetic neuropathy Eicosanoids, β-cell function, and diabetes Coronary artery calcification in obese youth: what are the phenotypic and metabolic determinants?Insulin sensitivity and arterial stiffness in youth with type 1 diabetes: the SEARCH CVD study.A review of the effect of diet on cardiovascular calcification.Adiponectin dysregulation and insulin resistance in type 1 diabetes.Testosterone concentration and insulin sensitivity in young men with type 1 and type 2 diabetes.Challenges in diagnosing type 1 diabetes in different populations.Adiponectin-SOGA Dissociation in Type 1 Diabetes.Features of hepatic and skeletal muscle insulin resistance unique to type 1 diabetes.Estimated insulin sensitivity predicts incident micro- and macrovascular complications in adults with type 1 diabetes over 6 years: the coronary artery calcification in type 1 diabetes study.Relation of Combined Non-High-Density Lipoprotein Cholesterol and Apolipoprotein B With Atherosclerosis in Adults With Type 1 Diabetes Mellitus Diabetes Complications in Childhood Diabetes-New Biomarkers and Technologies.Insulin Delivery Into the Peripheral Circulation: A Key Contributor to Hypoglycemia in Type 1 Diabetes Rising incidence and challenges of childhood diabetes. A mini review.Estimated insulin sensitivity and cardiovascular disease risk factors in adolescents with and without type 1 diabetes.Cardiovascular Risk in Children and Adolescents with Type 1 and Type 2 Diabetes Mellitus.The importance of palmitoleic acid to adipocyte insulin resistance and whole-body insulin sensitivity in type 1 diabetes Early signs of atherosclerosis are associated with insulin resistance in non-obese adolescent and young adults with type 1 diabetes Rapid GFR decline is associated with renal hyperfiltration and impaired GFR in adults with Type 1 diabetes.Insulin resistance in type 1 diabetes: what is 'double diabetes' and what are the risks?Development and Validation of a Method to Estimate Insulin Sensitivity in Patients With and Without Type 1 Diabetes.Myostatin inhibition therapy for insulin-deficient type 1 diabetes Early diabetic nephropathy: a complication of reduced insulin sensitivity in type 1 diabetes.Matrix Gla protein species and risk of cardiovascular events in type 2 diabetic patients.

P2860

Q26775403-A39B50A2-EA76-4138-B870-6355B174F026 Q26801901-58E38E82-2C4A-4D8F-960B-E76EA55F5F24 Q26823862-EB8DFBA9-C5EB-4FD6-928D-E69D2BF3FF98 Q27000205-E7F0A3A5-4B7A-44AE-867E-0E48A1A64E37 Q27009400-D11F8C22-0844-4526-ABA3-547147895AE4 Q30100978-7F022100-5685-4496-A076-B8A216D66050 Q34023089-4742B87B-E2CF-4AE6-9E98-A1D94F319988 Q34219439-E0237FE7-9EFC-419B-9DDA-0E7B84FA3328 Q34326924-E6EB3FDA-37D1-4383-A97A-F598C92E0499 Q34336580-2CF3813D-79F6-42D8-B958-9DA3191B6B0C Q34614907-9627EB10-A618-4E96-BDE4-DC138ECE7831 Q34845017-D1994021-282E-47F9-9BCC-0315CAA15338 Q34995698-F7FD0340-2C6E-4C6C-B96A-3B56D12818A8 Q35004291-0C99686A-F090-4153-856B-79248BDE25B2 Q35077618-2F3B09DB-DC09-4AAE-A6FA-C007B958CD30 Q35095336-2AB72187-11DF-4BB2-BCE0-E5C6B0ADE069 Q35129888-ECB47D30-8DFF-46AB-BA8C-0C93C2A1D3BD Q35360896-EDD85096-4FC6-4B73-BA5D-3CD65F16EC5E Q35554292-D89BD54D-67F8-4E07-BC95-7E6D688419EB Q35585755-EF5ED16C-6D41-41EF-9482-0A2B67EF6F69 Q35869547-FA62C181-E2E5-4E2B-AE43-4E6B4F6BFF02 Q35876203-EC339533-EA3F-468E-AA42-65E3D0FAAC72 Q35911114-101590D4-F398-412E-BCFC-99608F9498D6 Q35916487-46F30A54-4AFD-452F-A537-96C5C56C0E39 Q35921374-35E5FA96-C251-4470-91FA-818F5A01BBBA Q35943762-62C7D5BA-D489-44AB-9FE7-57AA86D5C10B Q36054342-C4558B85-013A-4D93-82DD-DD6740AEE12C Q36095944-7F1F1A85-27C3-43AA-AA0D-B3929EB6B3A7 Q36104684-BB62655A-4C4C-4995-B6A7-AC9F320D2151 Q36361747-61F4C792-6039-48F6-B274-2F99B516C93D Q36431312-220CBE9C-496A-49C7-990F-C518A223B252 Q36502062-B15CB2B0-DD8A-4E1F-A23F-DCC977627DFA Q36508961-E4B6ADC6-7EBB-4CEA-B7C1-B98D021FF0D1 Q36513259-DF080840-B5B5-4816-9E8F-8B5DA0BE18C3 Q36816866-AE6D3C32-BB78-43BF-8221-E1194CFF11CC Q36898042-B6F8AEBB-2A6D-4B48-8F7E-E0246750046B Q36935350-5EFF3703-7579-44D4-8BD1-9F8A2D0B192A Q37223399-901F1125-9462-4418-938C-B7E26658BB49 Q37278013-F3B06C83-EB18-446E-A767-1D41A11DD398 Q37278038-0398AC12-BD15-47EE-8F37-4A39ADB89B3F

P2860

Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study

http://www.wikidata.org/entity/Q34448739

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Insulin resistance, defective ...... pe 1 diabetes: The CACTI study

@ast

Insulin resistance, defective ...... pe 1 diabetes: The CACTI study

@en

Insulin resistance, defective ...... pe 1 diabetes: The CACTI study

@nl

type

label

Insulin resistance, defective ...... pe 1 diabetes: The CACTI study

@ast

Insulin resistance, defective ...... pe 1 diabetes: The CACTI study

@en

Insulin resistance, defective ...... pe 1 diabetes: The CACTI study

@nl

prefLabel

Insulin resistance, defective ...... pe 1 diabetes: The CACTI study

@ast

Insulin resistance, defective ...... pe 1 diabetes: The CACTI study

@en

Insulin resistance, defective ...... pe 1 diabetes: The CACTI study

@nl

P1433

Q34448739-1CD063D6-02D0-475F-8E81-3233F0BBB406

P1476

Q34448739-B35673B3-80E2-47CE-8D54-2DC6E79C0DF8

P2093

Q34448739-0F14AF4A-8F88-48C4-B2CA-6D37830D3968

Q34448739-28EDA2DB-850B-450F-B17E-25405759E938

Q34448739-5F877336-9EB8-4EAB-A581-5F0E5CF00308

Q34448739-8858A206-88D1-4DB7-B922-60232777CCC5

Q34448739-F13D685C-F18A-4CC9-8712-1C6F5D27EFA4

Q34448739-F5935048-935F-4B03-B2F6-C90B8B4C8705

P2860

Q34448739-072EC410-0176-4F84-A9A9-40B612C771FA

Q34448739-0961E84A-3E90-41C9-B9FC-0B4BE04E26B8

Q34448739-0DEE0C12-BDD3-4E87-9605-9AC8C1C52382

Q34448739-125D4414-3119-44D6-8974-66BB47C5B982

Q34448739-13019625-969C-4D19-A00A-6D08BBA82136

Q34448739-1ED270F6-5142-45C7-8CDE-5AA9F5E7B905

Q34448739-1F89F2D0-A74E-4DD4-83D2-838660BDC511

Q34448739-27372B90-A6FA-4025-BA83-9722B713D5A8

Q34448739-2B4405D2-08D2-4BE1-BDF8-10FCA1BA7E7B

Q34448739-2ED589E7-8C98-43F4-BEDB-C94F0F277945

P304

Q34448739-E7CD1E50-FB78-4A4C-9D7B-6950267F74D8

P31

Q34448739-EA255C6E-E9F7-449D-B85F-4382DC8C5B26

P356

Q34448739-D6D4D324-C3DD-47FC-B994-7670D0481DDA

P407

Q34448739-9C6F7F2B-DB38-4B6C-811D-C8C47870201D

P433

Q34448739-99E8EB90-343C-4689-9E9A-3E08C951909F

P478

Q34448739-7A1DE832-A89D-4540-8E8C-8F43F435674B

P50

Q34448739-99FCB92B-C8EE-4290-A4A4-67D2ED1B52E2

P577

Q34448739-FC806806-94FD-4C88-B651-BD840568087A

P5875

Q34448739-C12DF61E-BB26-45D2-BE17-9317B8C30317

P698

Q34448739-CAE931B7-5D6B-4B6C-8A88-F733C6E991E8

P921

Q34448739-56C7FFE5-BF08-4D7D-BADD-440EAF11AB0F

Q34448739-8973FF26-4F59-4896-9F4E-57BB2EB9379B

Q34448739-9959DF56-ED83-49FE-BC1C-FC37425F8A57

P932

Q34448739-CAC29A1F-CEF6-4921-B445-423CF6F58FC1

P356

P1433

P1476

Insulin resistance, defective ...... pe 1 diabetes: The CACTI study

@en

P2093

Adam Kretowski

http://www.w3.org/2001/XMLSchema#string

Bryan C Bergman

http://www.w3.org/2001/XMLSchema#string

David M Maahs

http://www.w3.org/2001/XMLSchema#string

Irene E Schauer

http://www.w3.org/2001/XMLSchema#string

Janet K Snell-Bergeon

http://www.w3.org/2001/XMLSchema#string

Robert H Eckel

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study.

Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study.

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.

Epidemiology of insulin resistance and its relation to coronary artery disease.

Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function.

Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (

Lipoprotein subfraction cholesterol distribution is proatherogenic in women with type 1 diabetes and insulin resistance.

Insulin resistance and cardiovascular disease.

P304

306-314

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB10-0328

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-10-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47555928

http://www.w3.org/2001/XMLSchema#string

P698

20978091

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

3012187

http://www.w3.org/2001/XMLSchema#string